Difference between revisions of "Team:Peking/Improve"

Line 351: Line 351:
  
 
Then, we drive the expression of Frb-yEGFP-HOTag6 with 3 promoters pUra3, pTEF1 and PDH3. As our <a href="https://2018.igem.org/Team:Peking/Model">Modeling</a> work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .3).
 
Then, we drive the expression of Frb-yEGFP-HOTag6 with 3 promoters pUra3, pTEF1 and PDH3. As our <a href="https://2018.igem.org/Team:Peking/Model">Modeling</a> work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .3).
−
 
+
<img src="https://static.igem.org/mediawiki/2018/d/d8/T--Peking--Demof5.png"><br/>
 +
<figcaption style="text-align:justify; text-justify:inter-ideograph;">
 +
Figure. 3A The formation of SPOT can be described as a phase separation process of three components. Two important variable, the concentration of components and the interaction strength are marked in the figure.
 +
<br/>
 +
Figure. 3B Flow Cytometry results of three promoters (Ura3, Tef2, and PDH3). The expression level of Ura3 is lowest while PDH3 is the strongest promoter.
 +
<br/>
 +
Figure. 3C RapaSPOT of different promoter combinations after 10 μM rapamycin induction. Two axes stand for the expression level of components. After 3 hours, Only SPOT system with high level of Frb can be observed.
 +
<br/>
 +
Figure. 3D Proportion of yeasts with granules after rapamycin induction. The rapamycin is from 1μM to 100 μM.
 +
</figcaption>
  
 
<br/>
 
<br/>

Revision as of 21:18, 16 October 2018

Improvement

In this section, you could see the Improvement.

Fuse with yEGFP

We fuse part BBa_K209496 (Frb) and BBa_K209023 (FKBP) with yEGFP, which make it visible in the yeast under fluorescent microscope. Then we got partBBa_K2601008(FKBP-yEGFP) and BBa_K2601007(Frb-yEGFP).

Afterward, we drive the expression of FKBP-yEGFP and Frb-yEGFP with 4 promoters pUra3, pTet07,pTEF1 and PDH3. The expression of these promoters were measure by flow cytometry(Fig. 1). We then got prats BBa_K2601021 (Tet07-Frb-yEGFP), K2601023 (PDH3-Frb-yEGFP), BBa_K2601025 (Tet07-FKBP-yEGFP), BBa_K2601026 (TEF1-FKBP-yEGFP), K2601027 (PDH3-FKBP-yEGFP).




What's more, we fused Frb-yEGFP with HOtag6 and fused FKBP-yEGFP with HOtag3. These two parts can form phase separation in the presence of rapamycin (Fig. 2). The original part BBa_K209496 (Frb) and BBa_K209023 (FKBP) have not this function. We uploaded 2 parts: BBa_K2601010 (Frb-yEGFP-HOTag6) and BBa_K2601011 (FKBP-yEGFP-HOTag3).
Then, we drive the expression of Frb-yEGFP-HOTag6 with 3 promoters pUra3, pTEF1 and PDH3. As our Modeling work predicts, the kinetics of a system depends on the concentration of the components and the interaction strength(Fig .3).

Figure. 3A The formation of SPOT can be described as a phase separation process of three components. Two important variable, the concentration of components and the interaction strength are marked in the figure.
Figure. 3B Flow Cytometry results of three promoters (Ura3, Tef2, and PDH3). The expression level of Ura3 is lowest while PDH3 is the strongest promoter.
Figure. 3C RapaSPOT of different promoter combinations after 10 μM rapamycin induction. Two axes stand for the expression level of components. After 3 hours, Only SPOT system with high level of Frb can be observed.
Figure. 3D Proportion of yeasts with granules after rapamycin induction. The rapamycin is from 1μM to 100 μM.